Top

Published in:

01-10-2018 | Original Article

Longitudinal Outcomes of Epicardial and Endocardial Pacemaker Leads in the Adult Fontan Patient

Authors: Geoffrey D. Huntley, Abhishek J. Deshmukh, Carole A. Warnes, Suraj Kapa, Alexander C. Egbe

Published in: Pediatric Cardiology | Issue 7/2018

Abstract

Placement of an epicardial pacemaker system is often preferred over an endocardial system in patients who have undergone a Fontan operation, but data are limited on how these two systems perform over time in patients with Fontan palliation. We performed a retrospective review of adults with Fontan palliation who had pacemaker implantation and interrogation data at Mayo Clinic from 1994 to 2014. Lead parameters, pacing mode, and polarity were collected at the earliest device interrogation report. Clinic notes and device interrogation reports were reviewed at implantation, 6 months, and yearly after implantation to determine impedance, capture threshold (CT), and energy threshold (ET). There were 87 patients with 168 leads in the study cohort. The mean follow-up time was 7.7 years (6 months–19 years). There were 143 epicardial leads (57 atrial and 86 ventricular) and 25 endocardial leads (20 atrial and 5 ventricular). There was no difference in the baseline lead parameters between epicardial and endocardial leads for impedance (610 ± 259 versus 583 ± 156 Ω, p = 0.93), CT (2.0 ± 1.3 versus 1.8 ± 1.3 V, p = 0.28), or ET (7.1 ± 12.5 versus 6.8 ± 18.1 µJ, p = 0.29). Compared to endocardial leads, ventricular epicardial leads were associated with temporal decrease in impedance and increase in ET. Regarding clinical outcomes, epicardial leads had higher rates of failure but similar generator longevity in comparison to endocardial leads. Ventricular epicardial leads were associated with temporal decrease in impedance and increase in ET. Epicardial leads had a higher rate of failure but similar generator longevity compared to endocardial leads.

Nakano T, Kado H, Tatewaki H, Hinokiyama K, Oda S, Ushinohama H, Sagawa K, Nakamura M, Fusazaki N, Ishikawa S (2015) Results of extracardiac conduit total cavopulmonary connection in 500 patients. Eur J Cardiothorac Surg 48(6):825–832. https://doi.org/10.1093/ejcts/ezv072 (discussion 832)CrossRefPubMed

Iyengar AJ, Winlaw DS, Galati JC, Wheaton GR, Gentles TL, Grigg LE, Justo RN, Radford DJ, Weintraub RG, Bullock A, Celermajer DS, d’Udekem Y (2014) The extracardiac conduit Fontan procedure in Australia and New Zealand: hypoplastic left heart syndrome predicts worse early and late outcomes. Eur J Cardiothorac Surg 46(3):465–473. https://doi.org/10.1093/ejcts/ezu015 (discussion 473)CrossRefPubMed

Ono M, Kasnar-Samprec J, Hager A, Cleuziou J, Burri M, Langenbach C, Callegari A, Strbad M, Vogt M, Horer J, Schreiber C, Lange R (2016) Clinical outcome following total cavopulmonary connection: a 20-year single-centre experience. Eur J Cardiothorac Surg 50(4):632–641. https://doi.org/10.1093/ejcts/ezw091 CrossRefPubMed

Pundi KN, Johnson JN, Dearani JA, Li Z, Hinck CA, Dahl SH, Cannon BC, O’Leary PW, Driscoll DJ, Cetta F (2015) 40-year follow-up after the Fontan operation: long-term outcomes of 1,052 patients. J Am Coll Cardiol 66(15):1700–1710. https://doi.org/10.1016/j.jacc.2015.07.065 CrossRefPubMed

Dabal RJ, Kirklin JK, Kukreja M, Brown RN, Cleveland DC, Eddins MC, Lau Y (2014) The modern Fontan operation shows no increase in mortality out to 20 years: a new paradigm. J Thorac Cardiovasc Surg 148(6):2517–2523 e2511. https://doi.org/10.1016/j.jtcvs.2014.07.075 CrossRefPubMed

Tweddell JS, Nersesian M, Mussatto KA, Nugent M, Simpson P, Mitchell ME, Ghanayem NS, Pelech AN, Marla R, Hoffman GM (2009) Fontan palliation in the modern era: factors impacting mortality and morbidity. Ann Thorac Surg 88(4):1291–1299. https://doi.org/10.1016/j.athoracsur.2009.05.076 CrossRefPubMed

Egbe AC, Connolly HM, Dearani JA, Bonnichsen CR, Niaz T, Allison TG, Johnson JN, Poterucha JT, Said SM, Ammash NM (2016) When is the right time for Fontan conversion? The role of cardiopulmonary exercise test. Int J Cardiol 220:564–568. https://doi.org/10.1016/j.ijcard.2016.06.209 CrossRefPubMed

Said SM, Burkhart HM, Schaff HV, Cetta F, Driscoll DJ, Li Z, Oliver WC Jr, Ammash NM, Dearani JA (2014) Fontan conversion: identifying the high-risk patient. Ann Thorac Surg 97(6):2115–2121. https://doi.org/10.1016/j.athoracsur.2014.01.083 (discussion 2121–2112)CrossRefPubMed

Williams MR, Shepard SM, Boramanand NK, Lamberti JJ, Perry JC (2014) Long-term follow-up shows excellent transmural atrial lead performance in patients with complex congenital heart disease. Circ Arrhythm Electrophysiol 7(4):652–657. https://doi.org/10.1161/CIRCEP.113.001321 CrossRefPubMed

10.

Walker F, Siu SC, Woods S, Cameron DA, Webb GD, Harris L (2004) Long-term outcomes of cardiac pacing in adults with congenital heart disease. J Am Coll Cardiol 43(10):1894–1901. https://doi.org/10.1016/j.jacc.2003.12.044 CrossRefPubMed

11.

Serwer GA, Mericle JM, Armstrong BE (1988) Epicardial ventricular pacemaker electrode longevity in children. Am J Cardiol 61(1):104–106CrossRef

12.

Lau KC, William Gaynor J, Fuller SM, Karen AS, Shah MJ (2015) Long-term atrial and ventricular epicardial pacemaker lead survival after cardiac operations in pediatric patients with congenital heart disease. Heart Rhythm 12(3):566–573. https://doi.org/10.1016/j.hrthm.2014.12.001 CrossRefPubMed

13.

McLeod CJ, Attenhofer Jost CH, Warnes CA, Hodge D 2nd, Hyberger L, Connolly HM, Asirvatham SJ, Dearani JA, Hayes DL, Ammash NM (2010) Epicardial versus endocardial permanent pacing in adults with congenital heart disease. J Interv Card Electrophysiol 28(3):235–243. https://doi.org/10.1007/s10840-010-9494-4 CrossRefPubMed

14.

Ramesh V, Gaynor JW, Shah MJ, Wieand TS, Spray TL, Vetter VL, Rhodes LA (1999) Comparison of left and right atrial epicardial pacing in patients with congenital heart disease. Ann Thorac Surg 68(6):2314–2319CrossRef

15.

Silvetti MS, Drago F, Di Carlo D, Placidi S, Brancaccio G, Carotti A (2013) Cardiac pacing in paediatric patients with congenital heart defects: transvenous or epicardial? Europace 15(9):1280–1286. https://doi.org/10.1093/europace/eut029 CrossRefPubMed

16.

Taliercio CP, Vlietstra RE, McGoon MD, Porter CJ, Osborn MJ, Danielson GK (1985) Permanent cardiac pacing after the Fontan procedure. J Thorac Cardiovasc Surg 90(3):414–419PubMed

17.

Takahashi K, Cecchin F, Fortescue E, Berul CI, Alexander ME, Walsh EP, Fynn-Thompson F, Triedman JK (2009) Permanent atrial pacing lead implant route after Fontan operation. Pacing Clin Electrophysiol 32(6):779–785. https://doi.org/10.1111/j.1540-8159.2009.02365.x CrossRefPubMedPubMedCentral

18.

Cohen MI, Vetter VL, Wernovsky G, Bush DM, Gaynor JW, Iyer VR, Spray TL, Tanel RE, Rhodes LA (2001) Epicardial pacemaker implantation and follow-up in patients with a single ventricle after the Fontan operation. J Thorac Cardiovasc Surg 121(4):804–811. https://doi.org/10.1067/mtc.2001.113027 CrossRefPubMed

19.

Shah MJ, Nehgme R, Carboni M, Murphy JD (2004) Endocardial atrial pacing lead implantation and midterm follow-up in young patients with sinus node dysfunction after the Fontan procedure. Pacing Clin Electrophysiol 27(7):949–954. https://doi.org/10.1111/j.1540-8159.2004.00564.x CrossRefPubMed

20.

Janson CM, Patel AR, Bonney WJ, Smoots K, Shah MJ (2014) Implantable cardioverter-defibrillator lead failure in children and young adults: a matter of lead diameter or lead design? J Am Coll Cardiol 63(2):133–140. https://doi.org/10.1016/j.jacc.2013.09.033 CrossRefPubMed

21.

Hamilton RM, Chiu C, Gow RM, Williams WG (1997) A comparison of two stab-on unipolar epicardial pacing leads in children. Pacing Clin Electrophysiol 20(3 Pt 1):631–636CrossRef

22.

Esperer HD, Singer H, Riede FT, Blum U, Mahmoud FO, Weniger J (1993) Permanent epicardial and transvenous single- and dual-chamber cardiac pacing in children. Thorac Cardiovasc Surg 41(1):21–27. https://doi.org/10.1055/s-2007-1013815 CrossRefPubMed

23.

Silka MJ, Rice MJ (1991) Paradoxic embolism due to altered hemodynamic sequencing following transvenous pacing. Pacing Clin Electrophysiol 14(4 Pt 1):499–503CrossRef

24.

Gillette PC, Zeigler V, Bradham GB, Kinsella P (1988) Pediatric transvenous pacing: a concern for venous thrombosis? Pacing Clin Electrophysiol 11(11 Pt 2):1935–1939CrossRef

25.

Fortescue EB, Berul CI, Cecchin F, Walsh EP, Triedman JK, Alexander ME (2004) Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm 1(2):150–159. https://doi.org/10.1016/j.hrthm.2004.02.020 CrossRefPubMed

26.

Zhang T, Liu Y, Zou C, Zhang H (2016) Single chamber permanent epicardial pacing for children with congenital heart disease after surgical repair. J Cardiothorac Surg 11(1):61. https://doi.org/10.1186/s13019-016-0439-6 CrossRefPubMedPubMedCentral

27.

Cohen MI, Bush DM, Vetter VL, Tanel RE, Wieand TS, Gaynor JW, Rhodes LA (2001) Permanent epicardial pacing in pediatric patients: seventeen years of experience and 1200 outpatient visits. Circulation 103(21):2585–2590CrossRef

28.

Silvetti MS, Drago F, Grutter G, De Santis A, Di Ciommo V, Rava L (2006) Twenty years of paediatric cardiac pacing: 515 pacemakers and 480 leads implanted in 292 patients. Europace 8(7):530–536. https://doi.org/10.1093/europace/eul062 CrossRefPubMed

29.

Sachweh JS, Vazquez-Jimenez JF, Schondube FA, Daebritz SH, Dorge H, Muhler EG, Messmer BJ (2000) Twenty years experience with pediatric pacing: epicardial and transvenous stimulation. Eur J Cardiothorac Surg 17(4):455–461CrossRef

30.

Noiseux N, Khairy P, Fournier A, Vobecky SJ (2004) Thirty years of experience with epicardial pacing in children. Cardiol Young 14(5):512–519. https://doi.org/10.1017/S1047951104005086 CrossRefPubMed

31.

Egbe AC, Huntley GD, Connolly HM, Ammash NM, Deshmukh AJ, Khan AR, Said SM, Akintoye E, Warnes CA, Kapa S (2017) Outcomes of cardiac pacing in adult patients after a Fontan operation. Am Heart J 194:92–98. https://doi.org/10.1016/j.ahj.2017.08.019 CrossRefPubMed

Title: Longitudinal Outcomes of Epicardial and Endocardial Pacemaker Leads in the Adult Fontan Patient
Authors: Geoffrey D. Huntley
Abhishek J. Deshmukh
Carole A. Warnes
Suraj Kapa
Alexander C. Egbe
Publication date: 01-10-2018
Publisher: Springer US
Published in: Pediatric Cardiology / Issue 7/2018
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-018-1919-3

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Longitudinal Outcomes of Epicardial and Endocardial Pacemaker Leads in the Adult Fontan Patient

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2018

Right Ventricular Systolic Function Parameters in Hypoplastic Left Heart Syndrome

Efficacy of Sports Club Activities on Exercise Tolerance Among Japanese Middle and High School Children and Adolescents After Fontan Procedure

Comparison of Clinical Profiles in Patients with Protein-Losing Enteropathy With and Without Fontan Circulation

Risk Factors for Failure of Systemic-to-Pulmonary Artery Shunts in Biventricular Circulation

Two-Dimensional Speckle Tracking Echocardiography-Derived Strain Measurements in Survivors of Childhood Cancer on Angiotensin Converting Enzyme Inhibition or Receptor Blockade

Short-Axis Diastolic Ventricular Area Ratio as a New Index in Screening Patients with Repaired Tetralogy of Fallot

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page